Editor's Highlight: Identification and Characterization of Teratogenic Chemicals Using Embryonic Stem Cells Isolated From a Wnt/β-Catenin-Reporter Transgenic Mouse Line.

Embryonic stem cells (ESCs) are commonly used for the analysis of gene function in embryonic development and provide valuable models for human diseases. In recent years, ESCs have also become an attractive tool for toxicological testing, in particular for the identification of teratogenic compounds. We have recently described a Bmp-reporter ESC line as a new tool to identify teratogenic compounds and to characterize the molecular mechanisms mediating embryonic toxicity. Here we describe the use of a Wnt/β-Catenin-reporter ESC line isolated from a previously described mouse line that carries the LacZ reporter gene under the control of a β-Catenin responsive promoter. The reporter ESC line stably differentiates into cardiomyocytes within 12 days. The reporter was endogenously induced between day 3-5 of differentiation reminiscent of its expression in vivo, in which strong LacZ activity is detected around gastrulation. Subsequently its expression becomes restricted to mesodermal cells and cells undergoing an epithelial to mesenchymal transition. The Wnt/β-Catenin-dependent expression of the reporter protein allowed quantification of dose- and time-dependent effects of teratogenic chemicals. In particular, valproic acid reduced reporter activity on day 7 whereas retinoic acid induced reporter activity on day 5 at concentrations comparable to the ones inhibiting the formation of functional cardiomyocytes, the classical read-out of the embryonic stem cell test (EST). In addition, we were also able to show distinct effects of teratogenic chemicals on the Wnt/β-Catenin-reporter compared with the previously described Bmp-reporter ESCs. Thus, different reporter cell lines provide complementary tools for the identification and analysis of potentially teratogenic compounds.

[1]  Maryam K. Mohammed,et al.  The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: Implications in targeted cancer therapies , 2015, Laboratory Investigation.

[2]  A. Luch,et al.  A Bmp Reporter Transgene Mouse Embryonic Stem Cell Model as a Tool to Identify and Characterize Chemical Teratogens. , 2015, Toxicological sciences : an official journal of the Society of Toxicology.

[3]  R. Nusse,et al.  An integral program for tissue renewal and regeneration: Wnt signaling and stem cell control , 2014, Science.

[4]  Kyung-Chul Choi,et al.  Role of the epithelial–mesenchymal transition and its effects on embryonic stem cells , 2014, Experimental & Molecular Medicine.

[5]  M. Kahn,et al.  The role of the Wnt signaling pathway in cancer stem cells: prospects for drug development , 2014, Research and reports in biochemistry.

[6]  M. Kahn,et al.  Wnt/Catenin Signaling in Adult Stem Cell Physiology and Disease , 2014, Stem Cell Reviews and Reports.

[7]  Shinya Oki,et al.  Epiblast Ground State Is Controlled by Canonical Wnt/β-Catenin Signaling in the Postimplantation Mouse Embryo and Epiblast Stem Cells , 2013, PloS one.

[8]  G. Calin,et al.  Wnt Signaling Regulates the Lineage Differentiation Potential of Mouse Embryonic Stem Cells through Tcf3 Down-Regulation , 2013, PLoS genetics.

[9]  Sean M. Wu,et al.  Early cardiac development: a view from stem cells to embryos. , 2012, Cardiovascular research.

[10]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions: insights from development , 2012, Development.

[11]  W. Pu,et al.  Endocardial and Epicardial Epithelial to Mesenchymal Transitions in Heart Development and Disease , 2012, Circulation research.

[12]  Hans Clevers,et al.  Wnt/β-Catenin Signaling and Disease , 2012, Cell.

[13]  G. Sapkota,et al.  The specificities of small molecule inhibitors of the TGFß and BMP pathways. , 2011, Cellular signalling.

[14]  Andrea E M Seiler,et al.  The validated embryonic stem cell test to predict embryotoxicity in vitro , 2011, Nature Protocols.

[15]  Mirjam Luijten,et al.  Transgenic animal models in toxicology: historical perspectives and future outlook. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[16]  Valérie Zuang,et al.  Alternative (non-animal) methods for cosmetics testing: current status and future prospects—2010 , 2011, Archives of Toxicology.

[17]  M. Schwarz,et al.  ReProGlo: a new stem cell-based reporter assay aimed to predict embryotoxic potential of drugs and chemicals. , 2010, Reproductive toxicology.

[18]  D. Seldin,et al.  Dynamic expression of a LEF‐EGFP Wnt reporter in mouse development and cancer , 2010, Genesis.

[19]  Peter W. Reddien,et al.  Wnt Signaling and the Polarity of the Primary Body Axis , 2009, Cell.

[20]  J. Campisi,et al.  Protocols to detect senescence-associated beta-galactosidase (SA-βgal) activity, a biomarker of senescent cells in culture and in vivo , 2009, Nature Protocols.

[21]  S. Bennett,et al.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative β-catenin , 2009, BMC Biology.

[22]  Marc W. Kirschner,et al.  Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling , 2009, Nature.

[23]  Xi He,et al.  Wnt/beta-catenin signaling: components, mechanisms, and diseases. , 2009, Developmental cell.

[24]  Nobue Itasaki,et al.  Crosstalk between Wnt and bone morphogenic protein signaling: A turbulent relationship , 2009, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  Walter Birchmeier,et al.  Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice. , 2008, Genes & development.

[26]  C. Mummery,et al.  Real time monitoring of BMP Smads transcriptional activity during mouse development , 2008, Genesis.

[27]  B. Doble,et al.  The ground state of embryonic stem cell self-renewal , 2008, Nature.

[28]  R. Moon,et al.  Biphasic role for Wnt/β-catenin signaling in cardiac specification in zebrafish and embryonic stem cells , 2007, Proceedings of the National Academy of Sciences.

[29]  Hans Clevers,et al.  Mining the Wnt pathway for cancer therapeutics , 2006, Nature Reviews Drug Discovery.

[30]  P. Chambon,et al.  Function of retinoid nuclear receptors: lessons from genetic and pharmacological dissections of the retinoic acid signaling pathway during mouse embryogenesis. , 2006, Annual review of pharmacology and toxicology.

[31]  A. Maggi,et al.  Reporter mice and drug discovery and development , 2005, Nature Reviews Drug Discovery.

[32]  Adrian Baddeley,et al.  spatstat: An R Package for Analyzing Spatial Point Patterns , 2005 .

[33]  Jens C. Streibig,et al.  Bioassay analysis using R , 2005 .

[34]  Andrew Gelman,et al.  R2WinBUGS: A Package for Running WinBUGS from R , 2005 .

[35]  Jeanette Wiltse,et al.  Mode of Action: Inhibition of Histone Deacetylase, Altering WNT-Dependent Gene Expression, and Regulation of Beta-Catenin—Developmental Effects of Valproic Acid , 2005, Critical reviews in toxicology.

[36]  D. Solter,et al.  Stabilization of β-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast , 2004, Development.

[37]  Susanne Bremer,et al.  Validation of the Embryonic Stem Cell Test in the International ECVAM Validation Study on Three In Vitro Embryotoxicity Tests , 2004, Alternatives to laboratory animals : ATLA.

[38]  M. Pfaffl,et al.  Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper – Excel-based tool using pair-wise correlations , 2004, Biotechnology Letters.

[39]  S. Dupont,et al.  Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  N. Brown Selection of Test Chemicals for the ECVAM International Validation Study on In Vitro Embryotoxicity Tests , 2002, Alternatives to laboratory animals : ATLA.

[41]  M. Lako,et al.  Characterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation , 2001, Mechanisms of Development.

[42]  D. Melton,et al.  A molecular mechanism for the effect of lithium on development. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Larue,et al.  Lack of beta-catenin affects mouse development at gastrulation. , 1995, Development.

[44]  J. Tobias,et al.  Universality and structure of the N-end rule. , 1989, The Journal of biological chemistry.

[45]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[46]  A. Honda,et al.  The teratogenic mechanism of 6-aminonicotinamide on limb formation of chick embryos: abnormalities in the biosynthesis of glycosaminoglycans and proteoglycans in micromelia. , 1982, Journal of biochemistry.

[47]  M. Weinstein,et al.  Cardiovascular Malformations with Lithium Use During Pregnancy , 1975 .

[48]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[49]  K. Storey,et al.  Retinoic acid orchestrates fibroblast growth factor signalling to drive embryonic stem cell differentiation , 2010, Development.

[50]  B. Herrmann,et al.  Immunohistochemical analysis of the Brachyury protein in wild-type and mutant mouse embryos. , 1994, Developmental biology.

[51]  C. Wilson,et al.  Position effects on eukaryotic gene expression. , 1990, Annual review of cell biology.